0001654954-19-010891.txt : 20190918 0001654954-19-010891.hdr.sgml : 20190918 20190918171116 ACCESSION NUMBER: 0001654954-19-010891 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190917 FILED AS OF DATE: 20190918 DATE AS OF CHANGE: 20190918 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hoberman Kenneth CENTRAL INDEX KEY: 0001573722 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32639 FILM NUMBER: 191100438 MAIL ADDRESS: STREET 1: 750 LEXINGTON AVENUE, 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10024 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TG THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001001316 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 363898269 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: (212) 554-4484 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 FORMER COMPANY: FORMER CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC DATE OF NAME CHANGE: 20030310 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC DATE OF NAME CHANGE: 20000330 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960703 4 1 section16.xml FORM 4 X0306 4 2019-09-17 0001001316 TG THERAPEUTICS, INC. TGTX 0001573722 Hoberman Kenneth 2 GANSEVOORT ST, 9TH FLOOR NEW YORK NY 10014 true false false false COMMON STOCK 2019-09-17 4 A false 27048 0 A 143953 D Reflects a grant of restricted shares that will vest on June 13, 2022. Includes shares of restricted Common Stock, which vest over various time periods. /s/ Kenneth Hoberman 2019-09-18